VUMC in the news, Oct. 4, 2022Sep. 30, 2022, 10:05 AM
A roundup of a few recent stories from the press about Vanderbilt University Medical Center:
William Schaffner, MD, professor of Preventive Medicine, continues to be one of the most in-demand sources about monkeypox, COVID-19, influenza and other subjects in the news. Among the news organizations he has spoken with recently: ABC News, Health, Healthline, NPR, Medical News Today and WebMD.
Stacie Dusetzina, PhD, professor of Health Policy, was quoted in a CNN story on Republican attack ads directed against Senate candidates in Arizona and Georgia. The ads make misleading claims about Medicare.
Healio reporter Isabella Hornick interviewed Brianne “Bree” Duncan, research nurse specialist III, and Sam S. Chang, MD MBA, Patricia and Rodes Hart Chair and Chief Surgical Officer of the Vanderbilt-Ingram Cancer Center, for a story about her being named as the first recipient of the Gail Kraemer Care Coordinator for Female Bladder Cancer Patients.
Carla Sevin, MD, associate professor of Medicine, was quoted in a New York Times opinion piece, “Where are all our post-COVID patients?”
WKRN Channel 2 interviewed James Antoon, MD, PhD, MPH, assistant professor of Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, about the upcoming flu season, what our hospital is seeing and reasons for a potentially hard season.
Medscape reporter Kerrie Rushton interviewed Bobo Tanner, MD, assistant professor of Osteoporosis, Rheumatology, Allergy in the Department of Medicine, for a story about new recommendations from the American College of Rheumatology on the prevention and treatment of glucocorticoid-induced osteoporosis.
Northwest Prime Time reporter John Schieszer and WKRN Channel 2 reporter Adam Mintzer interviewed Paul Newhouse, MD, director of the Vanderbilt Center for Cognitive Medicine, for a story about the news from Biogen and Eisai that lecanemab, a drug they are developing for Alzheimer’s disease, reduced cognitive decline by 27 percent in a clinical trial with 1,800 participants. The story will appear in six senior publications.